Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

50%

2 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 4
1(25.0%)
Phase 3
1(25.0%)
4Total
N/A(2)
Phase 4(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06114979Phase 3Unknown

Silodosin vs Placebo in the Treatment of Female LUTS

Role: collaborator

NCT03709992Not ApplicableSuspended

Trospium Chloride vs Tamsulosin in Treatment of Ureteral Stent Related Symptoms:

Role: collaborator

NCT03704623Phase 4Completed

Parecoxib vs Paracetamol in the Treatment of Acute Renal Colic

Role: collaborator

NCT03160469Not ApplicableCompleted

Prospective Study Of The Procedure-less Intra-gastric Elipse Balloon: Is It Effective & Safe?

Role: lead

All 4 trials loaded